IRCT2017071925160N6
Recruiting
Phase 4
Efficacy of different doses of Buprenorphine on reduction of withdrawal symptoms, anxiety, depression and suicidal thoughts
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Opioid dependency.
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria:age between 16 to 60 y/o; informed consent;Opioid dependence Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of other substances except Opioid as of the main substance
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Comparing how two different doses of an additive to bupivacaine heavy modifies the duration of action when used in lower limb surgeriesHealth Condition 1: S899- Unspecified injury of lower legCTRI/2022/01/039545Dr Ashik Sreekumar
Not yet recruiting
Phase 2
To Compare Two different Doses Of Drug Buprenorphine By Giving Block (Regional Anesthesia) and see for its Analgesic action and pain relief post operative periodHealth Condition 1: W19- Unspecified fallCTRI/2020/06/026126Dr Dnyaneshwari Munde
Not yet recruiting
Not Applicable
Prolongation of duration of Spinal AnaesthesiaHealth Condition 1: O- Medical and SurgicalCTRI/2020/04/024692Dr PSIMS RF
Not yet recruiting
Phase 4
Adding additive to spinal drug to see for pain relief after surgeryHealth Condition 1: O- Medical and SurgicalCTRI/2024/03/063780Ananya Krishna T
Completed
Not Applicable
Comparing of Buprenorphine with Placebo in Reducing Methamphetamine CravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine.Dependence syndromeIRCT201406017841N6Isfahan University of Medical Sciences, Behavioral Sciences Research Center40